• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受根治性膀胱切除术的淋巴结阳性膀胱癌患者中,是否有证据表明膀胱内肿瘤位置的一侧与同侧淋巴转移之间存在密切联系?PROMETRICS 2011数据库的结果。

Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.

作者信息

May M, Protzel C, Vetterlein M W, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm M O, Nuhn P, Bastian P J, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S, Aziz A, Hakenberg O W

机构信息

Department of Urology, St. Elisabeth-Hospital Straubing, St. Elisabeth-Straße 23, 94315, Straubing, Germany.

Department of Urology, University of Rostock, Rostock, Germany.

出版信息

Int Urol Nephrol. 2017 Feb;49(2):247-254. doi: 10.1007/s11255-016-1469-7. Epub 2016 Nov 28.

DOI:10.1007/s11255-016-1469-7
PMID:27896578
Abstract

PURPOSE

To evaluate the possible association between bladder tumor location and the laterality of positive lymph nodes (LN) in a prospectively collected multi-institutional radical cystectomy (RC) series.

METHODS

The study population included 148 node-positive bladder cancer (BC) patients undergoing RC and pelvic lymph node dissection in 2011 without neoadjuvant chemotherapy and without distant metastasis. Tumor location was classified as right, left or bilateral and compared to the laterality of positive pelvic LN. A logistic regression model was used to identify predictors of ipsilaterality of lymphatic spread. Using multivariate Cox regression analyses (median follow-up: 25 months), the effect of the laterality of positive LN on cancer-specific mortality (CSM) was estimated.

RESULTS

Overall, median 18.5 LN [interquartile range (IQR), 11-27] were removed and 3 LN (IQR 1-5) were positive. There was concordance of tumor location and laterality of positive LN in 82% [95% confidence interval (CI), 76-89]. Patients with unilateral tumors (n = 78) harbored exclusively ipsilateral positive LN in 67% (95% CI 56-77). No criteria were found to predict ipsilateral positive LN in patients with unilateral tumors. CSM after 3 years in patients with ipsilateral, contralateral, and bilateral LN metastasis was 41, 67, and 100%, respectively (p = 0.042). However, no significant effect of the laterality of positive pelvic LN on CSM could be confirmed in multivariate analyses.

CONCLUSIONS

Our prospective cohort showed a concordance of tumor location and laterality of LN metastasis in BC at RC without any predictive criteria and without any influence on CSM. It is debatable, whether these findings may contribute to a more individualized patient management.

摘要

目的

在一项前瞻性收集的多机构根治性膀胱切除术(RC)系列研究中,评估膀胱肿瘤位置与阳性淋巴结(LN)侧别之间的可能关联。

方法

研究人群包括2011年接受RC和盆腔淋巴结清扫的148例淋巴结阳性膀胱癌(BC)患者,这些患者未接受新辅助化疗且无远处转移。肿瘤位置分为右侧、左侧或双侧,并与阳性盆腔LN的侧别进行比较。采用逻辑回归模型确定淋巴转移同侧性的预测因素。使用多变量Cox回归分析(中位随访时间:25个月),评估阳性LN侧别对癌症特异性死亡率(CSM)的影响。

结果

总体而言,共切除中位18.5枚LN[四分位间距(IQR),11 - 27],3枚LN(IQR 1 - 5)为阳性。肿瘤位置与阳性LN侧别一致的比例为82%[95%置信区间(CI),76 - 89]。单侧肿瘤患者(n = 78)中,67%(95% CI 56 - 77)仅存在同侧阳性LN。未发现可预测单侧肿瘤患者同侧阳性LN的标准。同侧、对侧和双侧LN转移患者3年后的CSM分别为41%、67%和100%(p = 0.042)。然而,多变量分析中未证实阳性盆腔LN侧别对CSM有显著影响。

结论

我们的前瞻性队列研究显示,在RC时BC的肿瘤位置与LN转移侧别存在一致性,但无任何预测标准,且对CSM无任何影响。这些发现是否有助于更个体化的患者管理仍存在争议。

相似文献

1
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.在接受根治性膀胱切除术的淋巴结阳性膀胱癌患者中,是否有证据表明膀胱内肿瘤位置的一侧与同侧淋巴转移之间存在密切联系?PROMETRICS 2011数据库的结果。
Int Urol Nephrol. 2017 Feb;49(2):247-254. doi: 10.1007/s11255-016-1469-7. Epub 2016 Nov 28.
2
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.根治性膀胱切除术和扩大盆腔淋巴结清扫术:仅接受手术治疗的髂总血管分叉以上淋巴结转移患者的生存率。
J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14.
3
Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.根治性膀胱切除术时盆腔淋巴结清扫对肌层浸润性膀胱癌患者生存的不同影响。
Eur J Surg Oncol. 2015 Mar;41(3):353-60. doi: 10.1016/j.ejso.2014.10.061. Epub 2014 Nov 21.
4
Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.根治性膀胱切除术和标准化扩大淋巴结清扫术后淋巴结阳性膀胱癌的癌症特异性生存:通过淋巴结阳性和密度进行预测
BJU Int. 2009 Aug;104(3):331-5. doi: 10.1111/j.1464-410X.2009.08403.x. Epub 2009 Feb 11.
5
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.在接受根治性膀胱切除术的淋巴结阴性膀胱癌患者中,盆腔淋巴结清扫术时解剖的淋巴结数量与癌症特异性生存的关系。
Ann Surg Oncol. 2011 Jul;18(7):2018-25. doi: 10.1245/s10434-010-1538-6. Epub 2011 Jan 19.
6
Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.根治性膀胱切除术治疗临床淋巴结阳性膀胱癌患者,且未接受新辅助化疗的手术治疗。
World J Urol. 2018 Apr;36(4):639-644. doi: 10.1007/s00345-018-2190-1. Epub 2018 Jan 24.
7
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.根治性膀胱切除术联合盆腔淋巴结整块清扫术后盆腔淋巴结转移患者的危险因素:淋巴结密度概念
J Urol. 2003 Jul;170(1):35-41. doi: 10.1097/01.ju.0000072422.69286.0e.
8
Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.膀胱癌的临床淋巴结病:接受根治性膀胱切除术而未接受新辅助化疗的患者的横断面成像表现和肿瘤学结局的跨大西洋合作。
Eur Urol Focus. 2018 Mar;4(2):245-251. doi: 10.1016/j.euf.2016.11.005. Epub 2016 Nov 23.
9
The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.变异组织学分化对接受根治性膀胱切除术的淋巴结阳性膀胱癌患者的结外扩散及生存的影响。
Surg Oncol. 2019 Mar;28:208-213. doi: 10.1016/j.suronc.2019.01.008. Epub 2019 Jan 30.
10
Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.膀胱癌盆腔淋巴结转移:83例患者根治性膀胱切除及盆腔淋巴结清扫后的结局
J Urol. 2001 Jul;166(1):19-23.

引用本文的文献

1
Topography and Lateralization of Nodal Metastases in Muscle-Invasive Bladder Cancer Using Super-Extended Pelvic Lymph Node Dissection with the Sentinel Lymph Node Technique.使用前哨淋巴结技术的超扩大盆腔淋巴结清扫术对肌层浸润性膀胱癌淋巴结转移的部位及侧别分析
J Clin Med. 2024 Aug 29;13(17):5127. doi: 10.3390/jcm13175127.
2
Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.术前天门冬氨酸氨基转移酶/丙氨酸氨基转移酶比值作为原发性非肌肉浸润性膀胱癌的预后生物标志物:一项倾向评分匹配研究。
BMC Urol. 2021 Sep 27;21(1):136. doi: 10.1186/s12894-021-00901-9.
3

本文引用的文献

1
Treatment of muscle-invasive bladder cancer: A systematic review.肌层浸润性膀胱癌的治疗:一项系统评价。
Cancer. 2016 Mar 15;122(6):842-51. doi: 10.1002/cncr.29843. Epub 2016 Jan 15.
2
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
3
The role of cystectomy in elderly patients - a multicentre analysis.膀胱切除术在老年患者中的作用——一项多中心分析。
The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
术前评估的AST/ALT(德瑞蒂斯)比值对接受根治性膀胱切除术患者生存的预后意义。
Int Urol Nephrol. 2017 Sep;49(9):1577-1583. doi: 10.1007/s11255-017-1648-1. Epub 2017 Jul 1.
BJU Int. 2015 Oct;116 Suppl 3:73-9. doi: 10.1111/bju.13227. Epub 2015 Sep 2.
4
Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy.接受根治性膀胱切除术的患者中,膀胱三角区的膀胱内肿瘤累及与淋巴结转移相关。
Urology. 2014 Nov;84(5):1147-51. doi: 10.1016/j.urology.2014.05.011. Epub 2014 Aug 28.
5
The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review.淋巴结清扫范围对膀胱癌根治性切除术患者肿瘤学结局的影响:系统评价。
Eur Urol. 2014 Dec;66(6):1065-77. doi: 10.1016/j.eururo.2014.05.031. Epub 2014 Jul 26.
6
Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.前瞻性欧洲多中心队列研究中膀胱癌根治性膀胱切除术后 90 天死亡率的预测。
Eur Urol. 2014 Jul;66(1):156-63. doi: 10.1016/j.eururo.2013.12.018. Epub 2013 Dec 27.
7
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.EAU 指南:肌层浸润性和转移性膀胱癌:2013 年指南摘要。
Eur Urol. 2014 Apr;65(4):778-92. doi: 10.1016/j.eururo.2013.11.046. Epub 2013 Dec 12.
8
Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent.膀胱癌根治性膀胱切除术中的淋巴结清扫术:相关因素和范围的考虑。
Int Urol Nephrol. 2013 Dec;45(6):1561-7. doi: 10.1007/s11255-013-0503-2. Epub 2013 Jul 25.
9
The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer.在根治性膀胱切除术治疗肌层浸润性膀胱癌后,切除的淋巴结数量以及解剖模板与癌症特异性生存独立相关。
Int Urol Nephrol. 2013 Jun;45(3):711-9. doi: 10.1007/s11255-013-0461-8. Epub 2013 May 12.
10
Innovations in radical cystectomy and pelvic lymph node dissection.根治性膀胱切除术和盆腔淋巴结清扫术的创新。
Semin Oncol. 2012 Oct;39(5):573-82. doi: 10.1053/j.seminoncol.2012.08.012.